This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Li, Y. Articles by Ho, W.-Z. Search for Related Content PubMed PubMed Citation Articles by Li, Y. Articles by Ho, W.-Z.

(American Journal of Pathology. 2003;163:1167-1175.)
© 2003 American Society for Investigative Pathology

Morphine Enhances Hepatitis C Virus (HCV) Replicon Expression

Yuan Li^*, Ting Zhang^*, Steven D. Douglas^*, Jian-Ping Lai^*, Wei-Dong Xiao^*, David E. Pleasure and Wen-Zhe Ho^*

From the Divisions of Immunologic and Infectious Diseases,^*and Neurology and Neurology Research,Joseph Stokes, Jr. Research Institute at The Children’s Hospital of Philadelphia, Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania

Little information is available regarding whether substance abuse enhances hepatitis C virus (HCV) replication and promotes HCV disease progression. We investigated whether morphine alters HCV mRNA expression in HCV replicon-containing liver cells. Morphine significantly increased HCV mRNA expression, an effect which could be abolished by either of the opioid receptor antagonists, naltrexone or ß-funaltrexamine. Investigation of the mechanism responsible for this enhancement of HCV replicon expression demonstrated that morphine activated NF-B promoter and that caffeic acid phenethyl ester, a specific inhibitor of the activation of NF-B, blocked morphine-activated HCV RNA expression. In addition, morphine compromised the anti-HCV effect of interferon alpha (IFN-). Our in vitro data indicate that morphine may play an important role as a positive regulator of HCV replication in human hepatic cells and may compromise IFN- therapy.

This article has been cited by other articles:

				A. R Mani and K. P Moore New insights into the role of endogenous opioids in the pathogenesis of gastrointestinal and liver disease Gut, July 1, 2009; 58(7): 893 - 895. [Full Text] [PDF]

				H. Peyriere, L. Tatem, C. Bories, G.-P. Pageaux, J.-P. Blayac, and D. Larrey Hepatitis After Intravenous Injection of Sublingual Buprenorphine in Acute Hepatitis C Carriers: Report of Two Cases of Disappearance of Viral Replication After Acute Hepatitis Ann. Pharmacother., May 1, 2009; 43(5): 973 - 977. [Abstract] [Full Text] [PDF]

				H. Liang, X. Wang, H. Chen, L. Song, L. Ye, S.-H. Wang, Y.-J. Wang, L. Zhou, and W.-Z. Ho Methamphetamine Enhances HIV Infection of Macrophages Am. J. Pathol., June 1, 2008; 172(6): 1617 - 1624. [Abstract] [Full Text] [PDF]

				D. Chakass, D. Philippe, E. Erdual, S. Dharancy, M. Malapel, C. Dubuquoy, X. Thuru, J. Gay, C. Gaveriaux-Ruff, P. Dubus, et al. {micro}-Opioid receptor activation prevents acute hepatic inflammation and cell death Gut, July 1, 2007; 56(7): 974 - 981. [Abstract] [Full Text] [PDF]

				M R Ebrahimkhani, S Kiani, F Oakley, T Kendall, A Shariftabrizi, S M Tavangar, L Moezi, S Payabvash, A Karoon, H Hoseininik, et al. Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats Gut, November 1, 2006; 55(11): 1606 - 1616. [Abstract] [Full Text] [PDF]

				K. Moore and G. Dusheiko Opiate Abuse and Viral Replication in Hepatitis C Am. J. Pathol., November 1, 2005; 167(5): 1189 - 1191. [Full Text] [PDF]

				C.-Q. Wang, Y. Li, S. D. Douglas, X. Wang, D. S. Metzger, T. Zhang, and W.-Z. Ho Morphine Withdrawal Enhances Hepatitis C Virus Replicon Expression Am. J. Pathol., November 1, 2005; 167(5): 1333 - 1340. [Abstract] [Full Text] [PDF]

				Y. Li, T. Zhang, C. Ho, J. S. Orange, S. D. Douglas, and W.-Z. Ho Natural killer cells inhibit hepatitis C virus expression J. Leukoc. Biol., December 1, 2004; 76(6): 1171 - 1179. [Abstract] [Full Text] [PDF]